Rishikesh Kumar

Rishikesh Kumar

Auto-generated profile, based on publicly available information

Rishikesh Kumar

Indira Gandhi Inst Med Sci, Dept Microbiol, Patna, Bihar, India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2014 in Drug Delivery
Verified
Journal Article
Closed access
RKRishikesh Kumar
Rishikesh Kumar
GSGanesh Chandra Sahoo
Ganesh Chandra Sahoo
KPKrishna Pandey
Krishna Pandey
VDVnr Das
Vnr Das
PDPradeep Das
Pradeep Das
Drug delivery systems are a promising technology to increase poor solubility and bioavailability of compounds. Therefore we have developed PLGA-PEG encapsulated amphotericin B nanoparticles (NPs) drug delivery technology to increase the solubility of amphotericin B and target the macrophage of infected tissues during visceral leishmaniasis. The structural characterization by transmission electron microscopy and dynamic light scattering revealed the nano-size of the particle (30-35 nanometers). Fourier transform infrared spectroscopy confirmed the PLGA-PEG encapsulation. The mean cytotoxic assay (0.0803 + 0.0253) of extracellular promastigote of PLGA-PEG encapsulated amphotericin B is significantly lower than that of amphotericin B (0.1134 + 0.0153) and inhibition of amastigotes in the splenic tissue was significantly more than with conventional amphotericin B (93.02 + 6.63 versus 74.42 +14.78). Amphotericin B encapsulated PLGA-PEG nanoparticles were found to be more effective than free amphotericin B in terms of therapeutic efficacy during in vitro and in vivo study.


26 November 2022
Verified
Book Chapter
Closed access
PDF file
LMLakshmaiah Manjunatha
Lakshmaiah Manjunatha
GNGummeral Narasareddy
Gummeral Narasareddy
BRBankapura Mariyappa Ravikumar
Bankapura Mariyappa Ravikumar
LULeela Saisree Uppala
Leela Saisree Uppala
RKRishikesh Kumar
Rishikesh Kumar
BSBansa Singh
Bansa Singh